Biocardia Inc is a biotechnology company focused on developing innovative regenerative medicine therapies for heart disease and other cardiovascular conditions. The company is engaged in the research and development of cell-based and cellular therapies, leveraging advanced technologies to create treatments aimed at improving heart function and overall patient outcomes. Through its proprietary platforms, Biocardia seeks to address unmet medical needs in the field of cardiology, with the goal of enhancing the standard of care for patients suffering from chronic heart ailments. Read More
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.
